When it comes to buying an experienced cancer drug specialist, a bidding war is naturally expected. But in the case of Pfizer’s $11 billion deal for Array BioPharma, that didn’t happen. Still, it didn ...
Until recently phased array radar has been very expensive, used only for military applications where the cost of survival weighs in the balance. With the advent of low-cost microwave devices and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results